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PURPOSE 
A number of studies have provided evidence suggesting that 
5-hydroxytrypt amine (5-HT, serotonin), a substance found in the 
nervous system (and in other tissues), may play a role in the func¬ 
tioning of the nervous system. Several pharmacological substances 
have been shown either to alter the concentration of 5-HT in brain 
(reserpine, iproniazid, 5-hydroxytryptophane) or to antagonize or 
facilitate its action in some instances (lysergic acid diethylamide, 
abbreviated as: LSD-25 or simply LSD). 
It was therefore decided, for this study, to determine how 
these agents which influence 5-HT might affect certain measurable 
behavior of rats in their performance in a simple T-design water maze* 
The literature contains many studies reporting behavioral changes of 
a wide variety produced by some of the agents mentioned above, but 
to our knowledge does not contain a study of the effects on behavior 
by a group of compounds affecting 5-HT in at least partially known 
fashion* In addition, this study attempted to distinguish between 
drug effects on general motor reactivity and drug effects only on 
learned behavior—a distinction not rigorously made, to our knowledge, 
in previous studies. 
The investigation was concerned with: 
1* Comparing the undrugged, normal behavior of rats 
trained to swim a water maze with the behavior of these animals 
following the administration of the various drugs and drug combina¬ 
tions used. The measurements and observations made were: 
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a, Time required to reach the goal in the maze* 
b. Errors made in arriving at the goal* 
c* Other observable changes in behavior. 
2. Correlating any behavioral changes with known altera¬ 
tions in brain levels of 5-HT produced by the agents used. 
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HISTORICAL BACKGROUND 
A. Serotonin and the Central Nervous System. 
5-Hydroxytryptamine has a wide occurrence in the various 
tissues of vertebrates, invertebrates, and also in certain plants 
(Erspamer, 1954)* 
At the present time there is accumulating a considerable 
body of knowledge of its distribution in tissues, its biosynthesis 
and biotransformation, and its pharmacology, chiefly as concerns 
its actions on isolated organ systems* Its exact role in normal 
physiology, however, is unknown, and is a matter of some controversy. 
It appears likely that when its physiological significance is clari¬ 
fied, it will be associated with certain regulatory functions such 
as those now assigned to other potent, naturally-occurring amines 
like epinephrine, norepinephrine, and histamine. 
It is now well established that 5-HT appears in highest 
amounts in various portions of the gastrointestinal mucosa, in 
spleen, in brain, and in the platelets (Erspamer, 1954), Further¬ 
more, its biosynthesis has been clearly defined along one of the 
pathways of tryptophane metabolism, depicted by the following series 
of reactions (Clark et al., 1954; Gaddum and Giarman, 1956). (Fig. 1) 
These reactions are catalyzed by two enzymes: 
1. Tryptophane oxidase, which has been studied only in 
micro-organisms (Udenfriend et al., 1953)> and which catalyzes the 
oxidation of tryptophane to 5-hydroxytryptophane (5-HTP). 
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Figure 1 
Metabolism of Serotonin 
Notes : 1. Tryptophan hydroxylase is synonymous with tryptophane 
oxidase• 
2. Amine oxidase is synonymous with monoamine oxidase 
in this paper. 
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2, 5-Hydroxytryptophane decarboxylase, which has been 
shown to occur in a variety of tissues, including neural structures 
(Clark et al*, 1954j Gaddum and Giarraan, 1956). This enzyme con¬ 
verts 5-HTP to 5-HT by decarboxylation. 
Erspamer (1954) has reviewed six possible degradative 
pathways for 5-HT, among which oxidative deamination is probably the 
most important. The reaction, catalyzed by monoamine oxidase (see 
Figure 1), results in the formation of 5-hydroxyindole acetic acid 
(5-HIM), which appears in the urine as the primary metabolite of 
5-HT (Sjoerdsma et al., 1956). Blaschko (1952) in his review on 
monoamine oxidase, suggests that one of the main physiological func¬ 
tions of this enzyme is the destruction of 5-HT, It is of consider¬ 
able interest that this enzyme is found in neural tissue, including 
brain (Sjoerdsma et al., 1955)* 
5-HT possesses multiple and varied pharmacological effects 
chiefly referable to a potent stimulant action on the smooth muscle 
of various organs (Erspamer, 1954)* Because of this varied action, 
numerous hypotheses concerning its physiological role have been 
advanced, among them those reviewed by Erspamer (1954)# that it 
acts to: (l) cause hemostasis (by constricting vasculature at the 
site of an injury); (2) regulate arteriolar tone; (3) control 
renal function and renal hemodynamics. In addition, it has been 
suggested that 5-HT is responsible for the symptomatology seen in 
patients with carcinoid tumors (Sjoerdsma et L., 1956). 
The hypothesis pertinent to the present work concerns the 
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possible role of 5-HT in the function of the nervous system, and 
possibly in mentation. Gaddum (1953 a, b) was the first to suggest 
that the schizophrenic-like condition produced in man by LSD was 
due to a blocking of the central actions of 5-HT by LSD, This idea 
arose from an observation of the very potent antagonistic effect of 
LSD on the contractile response of the isolated rat’s uterus to 5-HT. 
Woolley and Shaw (1954 b) independently suggested that 
5-HT might play a part in maintaining normal function of the nervous 
system. This suggestion was based upon the facts that (a) 5-HT is 
a constituent of this tissue, and (b) many structurally related 
compounds (as LSD and 2,5-dimethyl benzylserotonin) which showed 
antagonism against 5-HT in some tissues also produced behavioral 
and psychiatric aberrations. They realized, however, that two 
objections to this hypothesis were that by no means all compounds 
showning anti-5-HT activity caused such aberrations, and that 5-HT 
given peripherally did not rectify the aberrations; but they pointed 
to the fact that when 5-HT is administered peripherally to the 
mouse, no detectable amount penetrates to the brain, it either 
being destroyed en route or being unable to pass the blood-brain 
barrier; so that the latter objection, at least, is not a strong 
one. 
A further objection, however, has been presented by Erspamer 
(1954), who noted the results of a very interesting experiment by 
Lewis and Mcllwain: a preparation of guinea pig cerebral cortex in 
which respiration and glycolysis had been depressed by LSD responded 
- 6 - 
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to administration of 5-HT, not by a lessening of the depression, but 
by a deepening of it. In connection with this, it is important to 
note the observations of Marrazzi and Hart (1955) and of Welsh and 
McCoy (1957) that in relatively low concentrations LSD mimics the 
actions of 5-HT rather than antagonizing them. 
It has been pointed out by Cerletti and Rothlin (1955) 
that a lysergic acid derivative, 2-brom-d-lysergic acid (BOL 14&) 
is as strong an antagonist of 5-HT as LSD in many tissues (including 
antagonizing the potentiating effect on barbiturates possessed by 
5-HT) but does not produce abnormal psychic disturbances, as LSD 
does. Such evidence stands against Woolley and Shaw* s hypothesis 
that "the suppression of /serotonin* sJ action results in a mental 
disorder11 (1954 a). 
Nevertheless, there is still much to suggest that 5-HT 
may play a role in neural functioning. Much of the evidence in favor 
of this hypothesis is based on indirect experimentation, because 
5-HT is difficult to utilize experimentally in the intact animal by 
introduction into the peripheral vasculature (as discussed above). 
Of this indirect evidence, among the most intriguing results 
have been the observations of Brodie and co-workers that the potent 
tranquilizing agent, reserpine, is capable of depleting all body 
stores of 5-HT, including brain, platelets, spleen, and gastrointes¬ 
tinal mucosa (Pletscher et al., 1955; Brodie et al., 1956). For 
example, rabbits and dogs treated with 2.5-5 mg./kg. of reserpine 
show greatly elevated urinary levels of 5-HIAA, and within 4-6 hours. 
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the brain level of 5-HT in these animals is not detectable (Brodie 
at al., 1955)* Furthermore, possibly more important, was the obser¬ 
vation that among the various alkaloids in Rauwolfia preparations, 
only the three active tranquilizers (reserpine, deserpidine, and 
rescinnamine) produce this 5-HT release (Brodie et al., 1956), 
Another line of indirect research, also by the Brodie 
group, has been the demonstration that 5-HT and reserpine can prolong 
the anesthesia induced by hexobarbital in mice, and that this poten¬ 
tiation is antagonized by LSD (Shore et al*, 1955)* Chlorpromazine 
also shows this potentiation, but is not antagonized by LSD, nor does 
it cause a 5-HT release (Brodie et al., 1956). 
In view of these data Brodie et al, have propounded a 
hypothesis explaining the central actions of reserpine on the basis 
that it impairs the ability of brain cells to hold 5-HT in a bound, 
inactive state and thus leads to a persistent low level of 5-HT in 
a free, active state. However, this hypothesis must be weighed in 
the light of recent evidence (Holzbauer and Vogt, 1956; Bertler et 
al., 1956) that reserpine also causes a release of norepinephrine 
from brain and other tissues. 
There is also a body of direct evidence favoring the hypo¬ 
thesis that 5-HT is active in neural functioning. 5-HT fulfills 
many of the criteria which one might establish for a substance 
operative in such functioning: 
1. 5-HT is present in nervous tissue. It has been found 
in animal brains in a non-random distribution, i.e., discreetly 
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localized in certain areas, chief among which have been the hypo¬ 
thalamus, medulla (especially the area postrema), mesencephalon, 
and nuclei euneatus and gracilis (Amin et al., 1954)* Neo-cortical 
areas are practically devoid of the amine5 but the limbic cortex 
and some of the subcortical nuclei associated with the limbic system 
have been found to be quite rich in 5-HT (MacLean et al., 1957). In 
addition to brain structures, recently it has been shown that a 
peripheral nervous structure, the superior cervical ganglion of the 
cat, is capable of producing 5-HT in appreciable quantities even 
though it apparently does not store it. This has been accomplished 
by perfusing the ganglion, in situ and while functioning under 
stimulation, with Ringer’s solution containing 5-HTP and iproniazid 
(Giarman et al., 1957). 
2. Nervous tissue has the capacity to synthesize 5-HT. 
The great majority of the areas cited above (except the area postrema) 
which contain relatively high concentrations of 5-HT have also been 
shown to contain 5-HTP decarboxylase (Gaddum and Giarman, 1956). 
Although 5-HT does not readily penetrate the blood-brain barrier, 
its precursor, 5-HTP, does readily enter the central nervous system. 
In experimental animals, levels of 5-HT as high as five to twenty 
times normal have been obtained by administering 5-HTP (Paasonen and 
Giarman, 1957; Udenfriend et al., 1956). 
3. Nervous tissue contains mechanisms for the rapid destruc¬ 
tion of 5-HT, among which the most important is monoamine oxidase. 
This destructive enzyme occurs in hypothalamus, medulla, cerebellum. 
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midbrain, thalamus, pons, and cortex, in descending order of activity 
(Bogdanski and Udenfriend, 1956). It is of interest in this regard 
that a potent inhibitor of monoamine oxidase, iproniazid (,Marsilid*) 
has been shown, when injected into animals, to raise brain levels 
of 5-HT as much as five times and to maintain this high level for 
several hours (Paasonen and Giarman, 1957; Chessin et al.t 1956). 
4. Introduction of 5-HT into nervous tissue alters its 
functioning. 5-HT has been introduced directly into the lateral 
ventricle of the cat and has produced a typical depressant effect, 
which is antagonized by LSD, among other substances (Gaddum and Vogt, 
1956)• In addition, Sherwood has introduced 5-HT into ventricles 
of schizophrenic patients and reported beneficial effects (Sherwood, 
1955). After the injection of 5-HT in doses of 15-75 micrograms, 
the patients (l) yawned and cleared their throats; (2) became 
pale and perspired; (3) showed a fall in pulse rate; (4) over 
the next one to three hours became active or even restless, started 
to talk readily and make contact, without any effect on thought 
processes or any evidence of distress. Over a period of weeks, with 
two or three injections per week, they improved stepwise, became 
employable and interested; their personal habits improved; their 
speech assumed greater relevance; they could spend time to some 
extent as part of a community. One case of paranoid schizophrenia 
improved so much after five injections — the delusions appeared to 
have gone — that the patient was able to leave the hospital for 
home; however, this case had had a modified leucotomy 18 months 
- 10 - 
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earlier, and had to return after three months at home 
B. Behavioral Effects of LSD and Reserpine. 
With the chance observation in 1943 by Hofmann that LSD 
produces a hallucinatory state in man (Stoll, 1947) resembling several 
of the features of schizophrenia, there followed an interest in the 
relation of LSD to that psychosis. There also followed innumerable 
studies on the behavioral effects of LSD in many species of animals. 
Such diverse changes as the following have been reported in the 
literature: (a) the nature of the webs spun by spiders after LSD 
medication (Witt, 1951); (b) dampening of motor overactivity of 
waltzing mice by LSD (Rothlin, 1953); and (c) vegetative, motor, 
and behavioral responses to LSD in the Siamese fighting fish (Abram¬ 
son and Evans, 1954). Some clinicians have found a beneficial effect 
of LSD in neurotic human beings, the drug releasing previously 
unconscious repressed material to consciousness and permitting its 
assimilation in psychotherapy. The material so produced bore a 
striking similarity to the dream and fantasy material of patients 
undergoing deep psychoanalysis (Sandison, 1954; Abramson, 1955)* 
However, many investigators have discovered that LSD may make the 
subject dangerous to himself or others and enjoin great care in its 
use (Elkes et al., 1955). 
The first Western re-evaluation of reserpine in neuropsy¬ 
chiatric conditions appeared in 1954 by Kline. This and subsequent 
clinical successes in the use of reserpine as a “tranquilizer1’ 
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(in states characterized by emotional turbulence and disorder) led 
to laboratory examination of the effects of the drug upon the 
behavior of normal animals and animals subjected to hallucinogenic 
substances. For instance, LSD produces a distinctive vibrating 
behavior in the guppy (Lebistes reticulatus); reserpine, alone 
among various substances tested, abolished this abnormal behavior 
(Keller and Umbreit, 1956), As another example, reserpine has often 
been shown to have effects in different species attributed to a 
depression of both performance and learning (Weiskrantz and Wilson, 
1956); however, most (if not all) of these studies are open to the 
objection that the deleterious effect upon learning is simply the 
result of the general depression in motor performance regularly 
seen after administration of reserpine. Other studies have indicated 
that reserpine has the ability to inhibit conditioned reflex behavior 
without influencing an elicited reflex. 
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EXPERIMENTAL METHOD 
The water maze used was a tank without a top, constructed 
of transparent plastic 3/16 inch thick. It had the following 
dimensions (see next page). 
Male albino rats of mixed Wistar and Sprague-Dawley strains 
were used. The albino rat was chosen as the experimental animal for 
the following reasons: 
1. Data are available concerning the changes in brain 
concentration of 5-HT produced in this species by reserpine, 
iproniazid, and 5-hydroxytryptophane, and concerning the interaction 
of LSD-25 with 5-HT. 
2. A large body of literature is available concerning 
maze learning and other maze behavior in this animal. 
During the six months*period when these experiments were 
conducted, the weights of the animals were progressively greater. 
In most instances, the starting weight was slightly over 200 grams; 
exceptionally it was slightly over 100, 
The maze was filled with water to a level of eight inches. 
The water temperature was maintained between 13 and 16 degrees 
Centigrade, because performance was found to be most constant within 
that range. A temperature of approximately 25° was first tried, but 
it proved to be a poor stimulus to learning the maze. 
The standard procedure for one trial was as follows: 
A small triangular plastic platform eight inches tall 
was placed in the tank at point RG, the goal (Figure 2). Plastic 
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FIGURE 2. FLOOR PLAN 
THE FOLLOWING SIDES WERE MADE OPAQUE 
BY ATTACHING THICK PAPER, SO THAT THE 
ANIMAL COULD NOT SEE THE GOAL1 
AB, BC, CD , AND EF, GH. 
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tops were put in place over both alleys RG and LG, to prevent the 
rat from climbing out of the maze from the platform at the end of a 
run. Then the animal was placed backwards in the maze at S, the 
experimenter always standing on the left side. A stopwatch was 
started. The rat, forced to swim, then began exploring the maze. 
Eventually, it would reach the platform and climb up to safety at 
which time the watch would be stopped. Thus, the time recorded was 
that time elapsed from the placing of the animal in the water to the 
successful attainment of the goal. An error was defined as consisting 
in the animal’s propelling all or most of its body into the alley 
not leading to the goal, after having reached the choice point, CP. 
Swinging the head back and forth at CP was not an error; the 
animal was unable to see the platform from that point* A regression 
consisted in swimming back into alley S after reaching CP. The 
animal was allowed to rest upon the platform between trials. 
For the second trial, a platform was placed at LG. The 
rat was removed from RG, held down out of the line of vision, and 
the platform at RG removed; then the rat was placed at S and the 
above procedure repeated. 
Successive trials always followed a RIRL alternation 
pattern. Each session consisted of 30 trials, with two minutes 
between trials; thus, a session lasted one hour. No animal 
received more than one session a day, except for one instance during 
the early training period. 
An animal was considered to have learned the maze when 
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its error curve ceased descending and showed a horizontal trend for 
five sessions. At this point, the rat’s time was also stable. 
Regressions were infrequent after the initial sessions. A repre¬ 
sentative learning curve for an animal may be seen in Figure 3* 
Most animals tested learned the maze. An occasional rat, 
at the first or second session, persisted in abortive paddling in 
a wrong alley until it became exhausted, flaccid, and began to drown. 
Such animals were, of course, not used thereafter. 
Not infrequently in the course of training, animals showed 
a tendency to prefer one side over the other, thus making an error on 
every other trial. Different sides were preferred by different 
animals, and a given animal might even prefer the right on one day, 
the left on another. This phenomenon showed some tendency to recur, 
in a less obvious form, during the drug treatments given after 
learning was ended. 
The five or more sessions constituting a plateau in error 
and time curves, at the end of learning, were considered the animal’s 
baseline performance, that is, its normal, undrugged maze performance. 
After an animal had received a drug, it was run on subsequent days 
until its performance again reached the baseline; this return to 
baseline occurred in every case. 
Drugs were administered in the following fashion: 
LSD-25 was given intraperitoneally (IP) in doses of 
100 and 300 micrograms per kilogram body weight. The animal’s 
maze session then began immediately, because it has been shown that 
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the half-life of LSD-25 is 10 minutes, and peak brain concentrations 
are achieved within the first 30 minutes. Later, LSD-25 was given 
subcutaneously (SC) in both doses; the session also began immediately 
after injection. 
Iproniazid (’Marsilid*) was given IP in a dose of 100 
mg,/kg. Sessions started four hours subsequently, when the elevated 
5-HT curve in the brain has been shown to have reached a peak plateau. 
Reserpine was administered SC in doses of 0.5, 1.0, 
2.0, and 2.5 mg./kg. Sessions began four hours later, when it has 
been shown that the brain levels of 5-HT are significantly reduced. 
Combination treatment: Iproniazid was given IP, 100 
mg./kg. The next day (approximately 24 hours later) reserpine was 
given SC in either the 1.0 or the 2.0 mg./kg. dose. Four hours 
folloiTring reserpine administration, the session began. 
5-HTP was administered IP in a dosage of 100 mg./kg. 
Sessions started one-half hour after administration, at which time 
it has been demonstrated that 5-HT levels have reached a high point 
in their elevation. 
As will be seen from the experimental results, because of 
the ineffectuality of several of the lower doses, each effective 
treatment found controls in lower doses of the same treatment. The 
only possible exception was 5-HTP; for this treatment the control 
was: an equal volume of NaCl alkalinized with NaOH to a pH equal to 
that of the 5-HTP solution (pH 8). (The initial week, animal 1 
received 5-HTP, animal 2, NaCl; during the succeeding week, treatments 
were reversed.) 
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No animal received more than one treatment program a week. 
No animal received a new treatment until its performance reached the 
baseline after the previous treatment* It is most probable that this 
kind of schedule allowed for the complete removal of any of the com¬ 
pounds used before the same or another compound was given to the same 
animal* 
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EXPERIMENTAL RESULTS 
The results are given in the following tables, a summary 
of all data being shown in Table 7. 
TABLE 1 
Baselines For All Animals 
Animal Time baseline (Mean time 
per trial, untreated, 
seconds) 
Error baseline (Total 
errors per session, 
untreated) 
LUA 5 0-5 
RL 5-3 2-6 
RU 4-5 0-5 
LP 4 2-6 
R3 3-4 2-7 
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TABLE 3 
Iproniazid. 100 mg./kg., IP 
Animal Weight Mean time Change in Total errors Change in Comments 
grams per trial 
(sec.) 
time of per 
performance 
{% baseline) 
session errors 
(% baseline) 
LUA 316 5 0 3 0 None 
RU 337 5 0 5 0 
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TABLE 4 
Reserpine, SC. 
Dose Animal Weight Mean time Increase in Total Increase in Animal 
mg./kg. grams per trial time of per- errors errors completed 
(sec.) formance per (% baseline) session (% baseline) session 
0.5 RL 411 6 0 8 25 yes 
1.0 RL 422 82 900 25 300 no 
1.0 RU 348 4 0 5 0 yes 
2.0 LP 336 49 1100 30 400 no 
2.0 LUA 336 5 0 5 0 yes 
2.0 LUA 358 15 200 12 140 no 
2.0 RL 430 23 200 14 130 no 
2.0 RU 332 20 300 8 60 no 
2.0 R3 276 23 325 17 230 no 
2.5 LUA 344 17 200 8 60 no 
Comments; The animals which failed to complete the session presented 
a characteristic and dependable (reproducible) picture. Having 
reached the platform, they sat motionless or flopped on it with head 
down and pressed against the side of the maze; the tail was curled 
in bizarre fashion around the corner of the maze or over its top. 
They found it difficult to mount the platform at all. They drifted 
as though disoriented or paddled persistently in a blind alley; 
after several minutes of this abortive behavior drowning seemed 
imminent and, after being pulled out, the animal was flaccid from 
exhaustion. 
The above numbers for time and performance of these animals 
are only approximate because of incomplete sessions. The deleterious 
effects persisted in subsequent sessions for two to four or more days. 
Recovery of these animals, however, was complete and no permanent damage 
was observed. 
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TABLE 5 
IPRONIAZID 100 mg./kg., IP, PLUS RBSERPINE 
Dose 
reserpine 
mg./kg. 
Animal Weight 
grams 
Mean time 
per trial 
(sec.) 
Increase in Total errors 
time of per- per session 
formance 
(% baseline) 
Increase in 
errors 
(% baseline ) 
1.0 LUA 368 5 0 2 0 
1.0 R3 240 3 0 3 0 
2.0 RL 427 10 25 13 116 
2.0 RU 360 9 80 9 80 
2.0 R3 244 4 0 10 40 
2.0 LP 280 5 25 11 80 
Comments; These animals, in contradistinction to those receiving reserpine 
alone, all finished their sessions. They often appeared to be stimulated, 
as the following comments recur throughout the records; "lively," "alert," 
"darted," "darted furiously." Effects lasted only one or two days. 
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TABLE 6 
5-HTP 100 rag,/kg., IP or equal vol. alk. NaCl 
Drug Animal Weight 
grams 
Mean time 
per trial 
(sec,) 
Change in Total errors 
time of per session 
performance 
baseline) 
Increase in 
errors (% 
baseline) 
Comments 
5-HTP R3 284 4 0 14 100 no effect 
2nd day 
5-HTP R3 288 4 0 6 0 second 
treatment 
5-HTP RU 476 5 0 5 0 
NaCl RU 476 4 0 2 0 
NaCl R3 280 4 0 6 0 
Note: Since R3 showed no changes in second treatment with 5-HTP, it is 
concluded the 100^ figure is insignificant. Thus, results with 5-HTP were 
uniformly negative. 
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DISCUSSION OF RESULTS 
It is apparent that, of the six drug treatments used in 
this study, two had a definite effect. Only (l) reserpine alone, 
and (2) iproniazid followed by 2,0 mg./kg. of reserpine produced 
observable and measurable changes. 
It is of great interest to note that these two treatments 
produced markedly different deleterious effects upon maze behavior, 
even though iproniazid by itself had no effect. Animals receiving 
reserpine alone assumed a characteristic posture, appeared easily 
fatigued and disoriented, these effects tending to last for several 
days, but most noticeable of all, every animal who had received an 
effective dose (usually 2.0 mg./kg., but sometimes lower) was 
unable to finish his maze session. In contrast, animals under the 
combination treatment always finished their sessions; they appeared 
to be stimulated rather than depressed, and the effects of treat¬ 
ment lasted only one or two days. As an additional difference, 
animals under reserpine alone had an increase in performance-time 
which was relatively greater than their increase in errors; just the 
reverse was true of rats receiving iproniazid and reserpine. 
One of the particular advantages of the experimental 
technique employed was the separation of the effect of a drug upon 
general motor reactivity from its effect upon learned discrimination. 
The speed of swimming should be an index of motor ability, while 
number of errors should depend upon the extent to which the learned 
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pattern had been retained. Previous techniques have not provided a 
method of differentiating these. If an animal fails to continue to 
perform a complicated rope-climbing trick after receiving reserpine, 
but is also grossly depressed in all motor behavior, it cannot be 
claimed that the drug had a primary, selective depressant effect 
upon learned reactions, or any direct, isolated influence upon 
higher cerebral functions. Using the present technique, it is 
apparent that the combination of iproniazid and 2.0 mg./kg. 
reserpine causes a deleterious effect on important learned reactions, 
without a corresponding detrimental effect on general motor reactivity. 
The data concerning errors made by animals under the combination 
treatment (Table 5) have been subjected to statistical analysis; 
they are statistically significant below the .01 level. We believe 
that the small increase in performance-time seen with this treatment 
is simply the inevitable concomitant of the increase in errors; it 
takes longer to swim a maze when making errors than it does to swim 
it flawlessly. 
It would seem that the effect of reserpine was great upon 
general motor ability. This result is entirely in accord with 
expectations, since the general sedative and motor-retarding effects 
of reserpine are well documented. 
It is highly significant that premedication with a substance, 
iproniazid, which itself induced no behavioral changes, greatly 
altered the picture seen after reserpine administration. Indeed, it 
would seem that the combination treatment abolished reserpine* s 
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depressant action on motor ability, for the animals were seen to 
swim in quite lively fashion, and appeared in no wise sedated. 
Both effective treatments had an adverse effect upon 
behavior in a survival situation. 
One formulation (akin to the acetylcholine hypothesis) 
which explains most of the known facts about 5-HT in brain is: the 
bulk of pre-formed 5-HT is normally held within cells in a non- 
diffusible, inactive state, away from receptors sensitive to it, 
and protected from destructive mechanisms. Certain drugs (like 
reserpine) release 5-HT from this state and may thus alter the 
function of the central nervous system. Such a formulation has 
taken on greater physiological significance recently with the 
finding of a tissue extract which may be a natural releaser of 
5-HT (Toh, 1956). This substance, found thus far in kidney, liver, 
and lung, is capable of releasing 5-HT (and histamine) from platelets 
into a freely diffusible, active form, available to monoamine oxi¬ 
dase and presumably to specific receptors. 
Walaszek and Abood (1957) have helped to clarify the 
intracellular distribution of 5-HT in brain tissue using differential 
centrifugation of rat brain homogenates. They find that the natural 
distribution is: 60-75% in the mitochondria, the remainder distribu¬ 
ted among the nuclear debris and supernatant fractions. However, 
Giarman and Shanburg (1957, unpublished) have shown that no 5-HT is 
present in the nuclei; thus the 25-40$ outside the mitochondria 
constitutes the 5-HT in the cytoplasmic sap, extracellular fluid. 
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and unbroken cells. After reserpine, the total amount of 5-HT in 
brain is greatly reduced, with no detectable amount in the mito¬ 
chondria (Walaszek and Abood, 1957)* 
Giarman (1957) in unpublished studies, has found that the 
following treatments greatly increase (about 3-5 times normal) 
the total 5-HT of brain: (1) iproniazid and (2) iproniazid plus 
reserpine (see also Paasonen and Giarman, 1957; Chessin et al.t 
1956)• However (and pending experimental verification) we assume 
that after treatment (l) the increased 5-HT remains in the mito¬ 
chondria, away from its receptor sites, whatever they may be. We 
further assume that after treatment (2) the elevated amount of 
5-HT due to the 5-HT-releasing action of reserpine is not held by 
the mitochondria, but freely diffuses into the cytoplasmic sap and/or 
the extracellular fluid, and is there in an active state. 
A word about the term "mitochondria" is in order. Walaszek 
and Abood utilize the same centrifugal field as is used for separating 
mitochondria from liver, and assume that they are dealing with 
mitochondria of brain. Perhaps a more correct term, in the current 
state of technique and knowledge, is simply "cytoplasmic brain 
particles." 
The data above, together with the assumptions just made, 
can be used to explain the inactivity of iproniazid alone, the 
activity of iproniazid plus reserpine, and the different activity of 
reserpine alone. After reserpine alone, 5-HT is released from 
the particles into an active state, but is rapidly catabolized by 
-30 - 
- • o o:."'. r ■- : : t v. i " . af.' • ■ ' ’l" 
- i 1 r - 
' < - !> 
i- f f.i' X X :■ ' I ,';f' MX : ' . . X. :l"r TXjX 
. - ■ ; ■ _ ;■ ,;r.. . . , :m ' ■./:> • mm. , <rJ ■ V I " 
. 
, :,o t r».” '• • 1 X'- X. ' ' • v> ’ •■■X ■ ■ > * ■. k "jf 
_ ' X ■" X-.-f v 
•. a,.4; OM; o- T.;. fn :,:i> (? . X . ' m' • i" M .tjr/U ?.X. ~ S'iJ'XwX 
\J ' ' . ..... . * 
• ' - •• . ' ’ 
. . XI ifl.Cg.LCQSMidrxB edS 
. 
SIlid&Tf qo*: TO* f.V:.li 8X 8jR ') L-**’* ,r OvIhH &d<j GSiXU.U i>OOdi 
- 
. 
oX‘:'j.bX/Ov^',I! ^-CqHixe 8X t-9gi?©Xwc r.i hSK Quoiixriofxt lo oXfis 
..rnid-tjerf 
t i £d t ■ - 
. 
x ,+rr odd bns bisfilftOini io 
- < '=• M.i -■( ' S'*: X . ■ :• r‘ -1 
monoamine oxidase and perhaps other destructive mechanisms* It is, 
of course, well established that reserpine releases 5-HT from its 
other body depots (e.g., platelets, spleen, and gut). 
Giarman has also found (1957, unpublished) that 5-HTP 
causes an increase in total 5-HT content of brain to 3-5 times the 
normal value. If it be assumed that this increased 5-HT is still 
stored by the particles and hence inactive, then the similarity of 
its action to that of iproniazid, and, as in the case of iproniazid, 
its lack of effect upon behavior in this study, can be understood. 
It would be of interest to test the combination 5-HTP plus reserpine 
in this behavioral study. 
The failure to obtain a significant behavioral effect 
from even large doses of LSD may have been due, among other factors, 
to the absence from the maze situation of visual cues. LSD produces, 
among other phenomena, alterations in vision, including blindness 
in monkeys (Evarts, 1956). 
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CONCLUSIONS 
With the use of a simple T-shaped water maze by which it 
was possible to distinguish between the effect of a drug on motor 
reactivity and its effect on learned behavior, the following 
conclusions were reached concerning the effect of drugs which 
influence serotonin on the behavior of rats in this maze: 
1. Lysergic acid diethylamide in doses up to 300 y/kg. 
failed to influence the rats' performance. 
2. Iproniazid and 5-hydroxytryptophane, each in doses 
known to cause considerable elevations in brain serotonin, also 
failed to influence the rats' behavior. 
3. Reserpine had a profound effect upon the animals' 
performance, which might be attributed to the general depressant 
action of the drug, in the doses used, on motor activity. 
A combination of iproniazid and reserpine, known to 
influence brain serotonin in a predictable fashion produced a highly 
statistically valid effect upon the animals' behavior, which differed 
from the effect of reserpine alone in that there was no depression 
of motor reactivity. 
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